3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
4
Ovarian Neoplasms
3
Endometrial Neoplasms
2
Small Cell Lung Carcinoma
1
Neoplasms
1
Bulbo-Spinal Atrophy, X-Linked
1
Breast Neoplasms
1
Advanced Breast Cancer
1
Adenocarcinoma of Lung
1
Interventions
enzalutamide
2
darolutamide
2
abiraterone
2
bicalutamide
1
abemaciclib
1
Prednisolone
1
Goserelin
1
Docetaxel
1
AZD5305
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Bulbo-Spinal Atrophy, X-Linked
×
AZD5305
×
90 days
×
Clear all
NCT07336446
2026-05-01
ANDROMEDA
AstraZeneca
Phase 1/2
Recruiting
300 enrolled